September 12, 2019
CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, will present at the International Society of Cell & Gene Therapy (ISCT) North America Regional Meeting, taking place September 13-15 in Madison, Wisconsin. CTI's John Booth, PhD, Principal Research Scientist - Real World Evidence, North America, will present in the session titled "Quality & Operations Track Session 8 - Real World Evidence and Applications in Product Development" on Sunday, September 15th at 10:45a local time.
"We are thrilled to have Dr. Booth be a part of the ISCT North America Regional Meeting," remarks Lynn Fallon, Co-founder and President of CTI. "We have a combined expertise in Real World Evidence and Cell & Gene Therapy that is unique to the industry, and we are excited to share our extensive knowledge with those attending."
ISCT is a global society of clinicians, regulators, technologists, and industry partners with a shared vision to translate cellular therapy into safe and effective therapies to improve patients' lives. ISCT members gain access to an influential global community of peers, experts, and organizations invested in cell therapy. ISCT offers a unique collaboration between academia, regulatory bodies, and industry partners in cell therapy translation.
CTI has contributed to one of the first approvals in the cell and gene therapy space and has been actively working with cell and gene therapies since nearly the advent of the technology, making them one of the industry's experts in regenerative medicine. CTI's work in regenerative medicine reaches across 400 sites in 30 countries around the world.
Dr. Booth has extensive experience in Real World Evidence, including spending more than a decade at the University of Alabama at Birmingham as an epidemiologist with experience in clinical and outcomes research in association with the American Heart Association and with Amgen. He also worked as a clinical trial project manager, a project lead, and principal investigator on natural history, health outcomes, comparative effectiveness, and safety studies. Dr. Booth also worked at the University of Chicago doing research sponsored by Sunovion and by the NIH, following a role as medical writer. He earned his Bachelor of Science in Biology from Birmingham-Southern College, and his Master in Science and Doctorate in Epidemiology from the University of Alabama at Birmingham.